DM: Carbohydrates (2007)
1. 8-13 yr of age
2. Diagnosis of type 1 diabetes mellitus for more than1 yr
3. Regular attendance in the diabetic clinic
4. No additional dietary restrictions
5. No other immediate family members with diabetes.
6. No medications that would affect appetite
7. Family able to read and write EnglishRecruitment: Pediatric patients in Melbourne's Royal Children's Hospital
Study design: Randomized Prospective Trial
Intervention:
Randomization and stratification to study protocol based on usual dietary regime as determined by 3-d food records:
- GG: instructed in low-GI diet before and during the study;
- CG: randomized to low- GI diet but had followed a carbohydrate counting diet before the study;
- GC: randomized to carbohydrate counting study but had followed a low-GI diet before the study.
- CC: instructed on carbohydrate counting diet before and during the study.
Blinding: Data analysis and clinical outcome measures were performed by researchers unaware of treatment allocation.
Statistical Analysis:
- sample size allowed for a 15% dropout rate and provided 80% power to reject the null hypothesis: that mean HbA1C levels after 12 months were the same in the two groups if a 10% difference was found.
- significance set at 5%
- intent-to-treat analysis performed
- results were analyzed using multiple linear regression or Spearman's correlation for continuous variables or with a cobiation of logistic regression or Pearson's chi-square analysis for categorical data
- nonnormal data were analyzed using Wilcoxon's rank-sum test.
- clinical data were adjusted for baseline values where specified
Timing of Measurements: 0, 3, 6, and 12 months
Dependent Variables
Independent Variables
- different written materials given to subjects to reinforce counseling
- 3-day food diaries kept at 1, 3, 6, and 12 months
- phone calls made 2 weeks before clinic visit to ensure compliance
-
Research RD instructed patient and parent at baseline with follow-up at each clinic visit.
-
GI, relative to a standard glucose value of 100, was calculated by summing the following: [grams of carbohydrate from the food item/total daily carbohydrate x 100 x GI of food item] of 284 carbohydrate-containing foods, 194 were assigned a known GI, but 90 were given "estimated" values based on the GI of similar foods
- height and weight
- physical activity
Control Variables
- baseline values
- insulin regimen, not different between groups
- reported physical activity, not significant between groups
Initial N: 104 subjects, 49 subjects were assigned to the carbohydrate counting (control) diet and 55 were assigned to low-GI diet.
Final N: 89; 11 dropped from carbohydrate exchange group and 4 dropped from GI group; (22% vs. 7%, P = 0.03). The dropout rate was especially higher for the GC group who previously followed a low-GI diet but were in the carbohydrate-counting group during the study (39% dropout rate).
Age: 10-12 yrs
Ethnicity: not specified
Other relevant demographics: duration of diabetes: 3-4 years
Anthropometrics: No differences in baseline measures or demographic data between study groups.
Location: Australia
HbA1c:
Children in the low-GI group had significantly better HbA1c values than those in the carbohydrate counting group. (8.05 ± 0.95 vs. 8.61 ± 1.37%, P = 0.05).
Dietary Intake
Percent of kcal: Carbohydrate: 49%, fat: 34%, non-milk extrinsic sugars: 7%, and 21 g dietary fiber.
There appeared to be a high proportion of subjects who underreport food intake (53% vs. 46% in the carbohydrate counting vs. the low-GI group). The dietary variables were reanalyzed, excluding underreporters but remained unchanged.
GI was not significantly different between the two groups, however at all time points the low GI study group had significantly greater proportion of subjects in the low GI range =, defined as a GI<55.
Incidence of Hyperglycemia
Rates of excessive hyperglycemic episodes (>15/month) were significantly lower in the low-GI group (35% vs. 66%, P=0.006)
Quality of Life Questionnaire
Both children and their parents reported that the low-GI diet was easier to follow, believed that the low-GI diet promoted better control of blood sugar and would choose to follow the low-GI diet over the carbohydrate counting diet.
There were no differences in insulin dose, hypoglycemic episodes, or dietary composition. Those in the low-GI diet group reported a better quality of life for both the child and parent.
Flexible dietary instruction based on the Food Guide Pyramid with an emphasis of low Glycemic Index foods improves HbA1C without increasing the risk for hypoglycemia and enhances the quality of life for children with diabetes.
Not-for-profit |
|
The dietary intervention was very similar for both study groups. The primary difference was that the low-GI groups were given information about foods with a low-GI index and were instructed to use at least 1 low-GI food at each meal, to incorporate low-GI foods in recipes and to eat a low-GI food when hungry between meals. Those counting carbohydrates were instructed to limit intake based on the carbohydrate content of each food.
Quality Criteria Checklist: Primary Research
|
|||
Relevance Questions | |||
1. | Would implementing the studied intervention or procedure (if found successful) result in improved outcomes for the patients/clients/population group? (Not Applicable for some epidemiological studies) | Yes | |
2. | Did the authors study an outcome (dependent variable) or topic that the patients/clients/population group would care about? | Yes | |
3. | Is the focus of the intervention or procedure (independent variable) or topic of study a common issue of concern to dieteticspractice? | Yes | |
4. | Is the intervention or procedure feasible? (NA for some epidemiological studies) | Yes | |
Validity Questions | |||
1. | Was the research question clearly stated? | Yes | |
1.1. | Was (were) the specific intervention(s) or procedure(s) [independent variable(s)] identified? | Yes | |
1.2. | Was (were) the outcome(s) [dependent variable(s)] clearly indicated? | Yes | |
1.3. | Were the target population and setting specified? | Yes | |
2. | Was the selection of study subjects/patients free from bias? | Yes | |
2.1. | Were inclusion/exclusion criteria specified (e.g., risk, point in disease progression, diagnostic or prognosis criteria), and with sufficient detail and without omitting criteria critical to the study? | Yes | |
2.2. | Were criteria applied equally to all study groups? | Yes | |
2.3. | Were health, demographics, and other characteristics of subjects described? | Yes | |
2.4. | Were the subjects/patients a representative sample of the relevant population? | Yes | |
3. | Were study groups comparable? | Yes | |
3.1. | Was the method of assigning subjects/patients to groups described and unbiased? (Method of randomization identified if RCT) | Yes | |
3.2. | Were distribution of disease status, prognostic factors, and other factors (e.g., demographics) similar across study groups at baseline? | Yes | |
3.3. | Were concurrent controls or comparisons used? (Concurrent preferred over historical control or comparison groups.) | Yes | |
3.4. | If cohort study or cross-sectional study, were groups comparable on important confounding factors and/or were preexisting differences accounted for by using appropriate adjustments in statistical analysis? | N/A | |
3.5. | If case control study, were potential confounding factors comparable for cases and controls? (If case series or trial with subjects serving as own control, this criterion is not applicable.) | N/A | |
3.6. | If diagnostic test, was there an independent blind comparison with an appropriate reference standard (e.g., "gold standard")? | N/A | |
4. | Was method of handling withdrawals described? | Yes | |
4.1. | Were follow-up methods described and the same for all groups? | Yes | |
4.2. | Was the number, characteristics of withdrawals (i.e., dropouts, lost to follow up, attrition rate) and/or response rate (cross-sectional studies) described for each group? (Follow up goal for a strong study is 80%.) | Yes | |
4.3. | Were all enrolled subjects/patients (in the original sample) accounted for? | Yes | |
4.4. | Were reasons for withdrawals similar across groups? | Yes | |
4.5. | If diagnostic test, was decision to perform reference test not dependent on results of test under study? | N/A | |
5. | Was blinding used to prevent introduction of bias? | Yes | |
5.1. | In intervention study, were subjects, clinicians/practitioners, and investigators blinded to treatment group, as appropriate? | ??? | |
5.2. | Were data collectors blinded for outcomes assessment? (If outcome is measured using an objective test, such as a lab value, this criterion is assumed to be met.) | Yes | |
5.3. | In cohort study or cross-sectional study, were measurements of outcomes and risk factors blinded? | N/A | |
5.4. | In case control study, was case definition explicit and case ascertainment not influenced by exposure status? | N/A | |
5.5. | In diagnostic study, were test results blinded to patient history and other test results? | N/A | |
6. | Were intervention/therapeutic regimens/exposure factor or procedure and any comparison(s) described in detail? Were interveningfactors described? | Yes | |
6.1. | In RCT or other intervention trial, were protocols described for all regimens studied? | Yes | |
6.2. | In observational study, were interventions, study settings, and clinicians/provider described? | N/A | |
6.3. | Was the intensity and duration of the intervention or exposure factor sufficient to produce a meaningful effect? | Yes | |
6.4. | Was the amount of exposure and, if relevant, subject/patient compliance measured? | Yes | |
6.5. | Were co-interventions (e.g., ancillary treatments, other therapies) described? | Yes | |
6.6. | Were extra or unplanned treatments described? | N/A | |
6.7. | Was the information for 6.4, 6.5, and 6.6 assessed the same way for all groups? | Yes | |
6.8. | In diagnostic study, were details of test administration and replication sufficient? | N/A | |
7. | Were outcomes clearly defined and the measurements valid and reliable? | Yes | |
7.1. | Were primary and secondary endpoints described and relevant to the question? | Yes | |
7.2. | Were nutrition measures appropriate to question and outcomes of concern? | Yes | |
7.3. | Was the period of follow-up long enough for important outcome(s) to occur? | Yes | |
7.4. | Were the observations and measurements based on standard, valid, and reliable data collection instruments/tests/procedures? | Yes | |
7.5. | Was the measurement of effect at an appropriate level of precision? | Yes | |
7.6. | Were other factors accounted for (measured) that could affect outcomes? | Yes | |
7.7. | Were the measurements conducted consistently across groups? | Yes | |
8. | Was the statistical analysis appropriate for the study design and type of outcome indicators? | Yes | |
8.1. | Were statistical analyses adequately described and the results reported appropriately? | Yes | |
8.2. | Were correct statistical tests used and assumptions of test not violated? | Yes | |
8.3. | Were statistics reported with levels of significance and/or confidence intervals? | Yes | |
8.4. | Was "intent to treat" analysis of outcomes done (and as appropriate, was there an analysis of outcomes for those maximally exposed or a dose-response analysis)? | Yes | |
8.5. | Were adequate adjustments made for effects of confounding factors that might have affected the outcomes (e.g., multivariate analyses)? | Yes | |
8.6. | Was clinical significance as well as statistical significance reported? | Yes | |
8.7. | If negative findings, was a power calculation reported to address type 2 error? | Yes | |
9. | Are conclusions supported by results with biases and limitations taken into consideration? | Yes | |
9.1. | Is there a discussion of findings? | Yes | |
9.2. | Are biases and study limitations identified and discussed? | Yes | |
10. | Is bias due to study's funding or sponsorship unlikely? | Yes | |
10.1. | Were sources of funding and investigators' affiliations described? | Yes | |
10.2. | Was the study free from apparent conflict of interest? | Yes | |